AC Immune (ACIU) Operating Margin (2016 - 2025)
Historic Operating Margin for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 1721.62%.
- AC Immune's Operating Margin fell 17501400.0% to 1721.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 1678.03%, marking a year-over-year decrease of 15414500.0%. This contributed to the annual value of 191.8% for FY2024, which is 1705000.0% up from last year.
- Per AC Immune's latest filing, its Operating Margin stood at 1721.62% for Q3 2025, which was down 17501400.0% from 1484.53% recorded in Q2 2025.
- AC Immune's Operating Margin's 5-year high stood at 1869700.0% during Q4 2022, with a 5-year trough of 862550.0% in Q1 2021.
- For the 5-year period, AC Immune's Operating Margin averaged around 40616.7%, with its median value being 3051.09% (2024).
- Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2022, then plummeted by 2000000000bps in 2023.
- Quarter analysis of 5 years shows AC Immune's Operating Margin stood at 3956.08% in 2021, then skyrocketed by 47361bps to 1869700.0% in 2022, then plummeted by -100bps to 1082.87% in 2023, then tumbled by -51bps to 1637.47% in 2024, then fell by -5bps to 1721.62% in 2025.
- Its Operating Margin stands at 1721.62% for Q3 2025, versus 1484.53% for Q2 2025 and 1956.57% for Q1 2025.